SANTA FE, N.M., Oct. 16, 2017 -- Sigma Labs, Inc. (NASDAQ:SGLB) (“Sigma Labs” or the “Company”), a provider of quality assurance software under the PrintRite3D® brand, today announced that it will unveil its PrintRite3D® INSPECT™ V3.0 quality assurance software at the international Formnext 2017, powered by tct conference, (www.formnext.com), that will showcase current and future cutting-edge applications of additive technologies.
Sigma Labs' PrintRite3D® INSPECT™ V3.0 software is a web-based, distributed application featuring 3D Thermal Mapping of the melt pool using Sigma Labs’ proprietary TED™ (Thermal Emission Density™) metrics. These metrics are an industry first and powered by an advanced analytics engine, designed to meet the needs of users focused on research, development and qualification-level activities as well as day-to-day production activities. The researcher tools utilize in-process sensor data without the need for baseline comparisons providing users the data and framework for focused characterization and analysis leading to rapid process qualification and part certification. Quantitative, in-situ thermal history maps can also be used to validate modeling and simulation (M&S) results prior to process characterization studies, process qualification & validation phases, as well as in conjunction with design optimization evaluations.
“We are very pleased to unveil our next generation PrintRite3D® INSPECT™ Version 3.0 software which includes deep learning algorithms and visualization tools that provide users with unparalleled process characterization, qualification and validation capabilities across the additive manufacturing product QA continuum,” said Mark Cola, President and Chief Technology Officer of Sigma Labs. “We believe this release is a milestone achievement for Sigma Labs and the additive manufacturing industry as we drive our products to meet Industry 4.0 standards,” he added.
“We believe that Sigma’s PrintRite3D® INSPECT™ 3.0 software dramatically enhances additive manufacturing production capabilities with an ease of integration and use that sets Sigma Labs’ solutions apart from anything on the market,” said John Rice, Sigma Labs' CEO. “We are excited to unveil this next generation additive manufacturing solution at Formnext 2017, a forum that could not be more fitting for this release.”
About Formnext 2017
Formnext 2017, powered by tct conference, (www.formnext.com), takes place from November 14-17, 2017 at the Messe Frankfurt, Frankfurt, Germany and will showcase current and future cutting-edge applications of additive technologies. The event will also cover a wide range of prominent discussion topics from the surrounding industry, from the latest advancements in product development and industrial manufacturing to design, ongoing vocational training, and related legal parameters.
About Sigma Labs, Inc.
Sigma Labs provides the aerospace and defense industries with a sensor based software system that can detect flaws in metal parts as they are being manufactured using 3D printing. If adopted by the industry, Sigma Labs' products would provide dramatic savings to the Company's clients and facilitate an industry-wide transition from traditional multi-part manufacturing to real time plug and play 3D manufacturing for high strength metal parts. The Company's clients include GE, Honeywell, Siemens, Woodward, Aerojet Rocketdyne and others. For more information please visit us at www.sigmalabsinc.com.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company’s forward-looking statements, please see the Company’s Annual Report on Form 10-K (including but not limited to the discussion under “Risk Factors” therein) filed with the SEC on March 31, 2017 and which may be viewed at http://www.sec.gov.
Investor Relations Contact:
Bret Shapiro
Managing Director
CORE IR
561-479-8566
[email protected]


Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 



